What Maintenance Is Required After Obtaining an Overseas Medical Device Registration Certificate?

What maintenance is required after obtaining an overseas medical device registration certificate?

Answer: Once an overseas medical device registration certificate has been granted, the manufacturer remains responsible for maintaining certificate validity, managing product changes, updating labelling and IFU versions, keeping importer and authorised representative information current, and fulfilling adverse event reporting, complaint handling, recall procedures, post-market surveillance, annual fee and regulatory update obligations. Obtaining the certificate is only the beginning of market access: if follow-up maintenance is not properly executed, continued sales, certificate renewal and distributor or channel transitions may all be affected.

This guidance was compiled by the AIMEILI Regulatory Editorial Team based on publicly available regulatory materials, registration practice and the medical device international registration knowledge base.

Published: 8 July 2026, 09:00. Last updated: 8 July 2026, 09:00.

Key points at a glance

After obtaining an overseas medical device registration certificate, companies must still maintain the certificate expiry date and renewal schedule, product change control, labelling and IFU updates, importer or authorised representative information, adverse event reporting, complaint handling, recall procedures, post-market surveillance, annual fees and regulatory updates. Market authorisation is a continuing obligation rather than a one-off milestone, and gaps in post-market maintenance can disrupt ongoing sales, renewal applications or changes of local channel partners.

Who should read this

This content is intended for manufacturers, regulatory affairs specialists, international business leads and CRO teams that are planning overseas medical device registration, preparing to enter GHWP member states and other key markets, or assessing documentation gaps and registration pathways.

How to assess your position

Companies should first define the target country, device risk classification, intended use, existing registration basis and commercial launch plan. Only then should they determine the applicable regulatory pathway, depth of documentation, local agent requirements and post-market maintenance responsibilities. The same device may be classified differently and subject to different evidence requirements in different countries, so domestic registration conclusions cannot simply be transferred to overseas markets.

Documentation priorities

• Establish a certificate register with renewal reminders.
• Record product changes and labelling versions.
• Clarify the roles and post-market responsibilities of the local agent and importer.
• Track regulatory updates and reporting obligations in each target country.

Common misconceptions

• Preparing documents mechanically according to a checklist without first confirming the product classification.
• Overlooking local agent and labelling requirements.
• Underestimating the workload involved in supplementary testing and translation.
• Treating the registration certificate as a one-off task and neglecting post-market maintenance.

AIMEILI perspective

AIMEILI recommends that companies design a certificate maintenance mechanism before the certificate is even granted. For multi-country registration programmes in particular, a single, unified certificate register and a structured change assessment process should be established to keep renewals, variations and reporting obligations under control.

Related reading

• How do UDI and product classification codes affect overseas registration?
• How should medical device companies select their first batch of target countries for international expansion?
• How is a technical file gap assessment carried out for overseas medical device registration?
• What are the EU MDR technical documentation requirements for medical devices?
• What procedures are required to export Chinese medical devices to Indonesia?
• What are the overseas registration requirements for AI-based medical devices?

Content review and scope

Content author: AIMEILI Regulatory Editorial Team. Professional review: AIMEILI Medical Device International Registration Project Team. Source principle: priority is given to official regulatory authorities, international organisations, standards bodies and publicly available regulatory materials; industry media and project experience are used only as supporting reference. Scope: this article supports preliminary understanding, documentation preparation and project planning. It does not replace the formal requirements of the target country regulatory authority, testing conclusions or legal advice.